Form 4 for CNMD CONMED Corp
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001127602-22-009761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-17 | 2022-03-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | M - OptEx | $41.93 | +15.0K | 22.4K | +201% | +$629.0K |
| D | 2022-03-17 | 2022-03-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | F - Tax | $138.85 | -8,650 | 13.8K | -39% | -$1.20M |
| D | 2022-03-17 | 2022-03-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | S - Sale+OE | $138.43 | -2,500 | 7,449 | -25% | -$346.1K |
| D | 2022-03-17 | 2022-03-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | M - OptEx | $0.00 | -15.0K | 96.7K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | M | A | 15,000 | $41.93 | 22,449 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-15 | F | D | 8,650 | $138.85 | 13,799 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-15 | S | D | 2,500 | $138.43 | 7,449 | D | — | — | |
| 4 | Derivative | Options To Purchase Common Stock | 2022-03-15 | M | D | 15,000 | $0.00 | 96,650 | D | $41.93 · — to 2027-03-01 | 15,000 Common Stock | (F1) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |